Quality Planning Ahead for 2020

Orthoplastics development of a new facility planned for 2020, has had the Quality Team thinking about all aspects of Quality within a new manufacturing area. The new building, set to open in February 2020, will enable Orthoplastics to further increase its market capabilities with over £5 million of investment annually.

This is a significant move for the business in a rapidly advancing and innovative market and one that is fully supported by US parent company, Viant Inc. By planning ahead, we are already thinking about our Quality Management system, and how we can utilise this at the new facility.

We are in the process of validating our Quality management software, by updating our current software to a web-based version. By doing so we are still maintaining all aspects of the quality management system, such as document, audit and corrective action management, but will also enable greater functionality between users, particularly between various sites.

By forward planning, we are ensuring that our Quality Management System is at the forefront of our plans for Orthoplastics expansion. Incorporation of SQDC (Safety, Quality Delivery, cost) into manufacturing areas throughout the organisation has enabled manufacturing areas to be at the forefront of collecting quality data and reviewing improvement solutions.

Our Quality team are using data collected from SQDC techniques to refocus our continuous improvement strategy and use of the SQDC tool will align Orthoplastics quality management system and improve communication of quality-related activities to all employees, driving our values into each department.

Achievements of Quality Systems and Accreditations

At Orthoplastics, quality encompasses everything across all aspects of production, from customer service, to design and manufacture of our premium grade medical plastics.

A series of Quality Systems and Accreditations form the foundations of Orthoplastics success. Using the requirements of 21 CFR 820 as a guide, we are certified to ISO 13485 and ISO 14001.

Employing traceability techniques during the manufacturing of all our medical grade product, allows us to regularly assess product quality. All data is recorded and stored for a minimum of 30 years after the manufacturing processes.